I had a heterogeneous endometrium measuring 27 mm on a transvaginal ultrasound two years ago; am I at risk for endometrial pathology and should I undergo repeat imaging and biopsy?

You Need Evaluation Now

A 27 mm heterogeneous endometrium from two years ago requires immediate repeat transvaginal ultrasound and likely endometrial sampling, as this thickness significantly exceeds normal thresholds and carries substantial risk for endometrial pathology including hyperplasia and cancer.

Why This Matters

Your endometrial thickness of 27 mm is dramatically abnormal regardless of menopausal status. The heterogeneous appearance compounds the concern, as this texture pattern is specifically associated with endometrial hyperplasia and malignancy 1.

Critical Thresholds You've Exceeded

For context on how abnormal 27 mm is:

• Postmenopausal women: Endometrium >5 mm warrants biopsy; >11 mm in asymptomatic women carries 6.7% cancer risk 1, 2
• Premenopausal women: While no absolute cutoff exists, 27 mm with heterogeneous appearance is pathological 1
• Your measurement: At 27 mm, you're 2-5 times beyond concerning thresholds

The heterogeneous appearance is particularly worrisome. Research specifically identifies "thick irregular endometrium" and "cystic areas in the endometrium" as ultrasound criteria requiring biopsy to exclude cancer 3. A heterogeneous cystic endometrium is associated with prolonged proliferative phases from chronic anovulation and endometrial hyperplasia 4.

What You Must Do Immediately

Step 1: Repeat Transvaginal Ultrasound

Get this scheduled within 1-2 weeks. The sonographer should specifically assess:

• Current endometrial thickness
• Endometrial texture (homogeneous vs. heterogeneous)
• Endometrial-myometrial junction clarity
• Presence of cystic areas or irregular borders
• Vascularity patterns on Doppler

Step 2: Endometrial Sampling Based on Current Findings

If endometrium remains thickened (>11 mm postmenopausal, >15 mm premenopausal with symptoms):

• Office endometrial biopsy using Pipelle device (99.6% sensitive for cancer) 5
• If biopsy insufficient or negative but symptoms persist: hysteroscopy with directed biopsy 5

If endometrium now measures ≤4 mm (postmenopausal):

• Negative predictive value for cancer approaches 100% 1
• Can defer biopsy but maintain surveillance

Why Two Years Changes Everything

The critical issue: Endometrial cancers can be missed on initial imaging 1. Even if you were asymptomatic then, the natural history of endometrial pathology means:

• Simple hyperplasia can progress to atypical hyperplasia
• Atypical hyperplasia carries 30-60% risk of concurrent or subsequent cancer
• Endometrial cancer in early stages is 90% curable, but delays worsen outcomes 5

The two-year gap means any pathology present then has had ample time to progress. You cannot assume that absence of symptoms equals absence of disease.

Additional Considerations

If You Have Risk Factors

The following increase urgency:

• Age >50 years
• Obesity (BMI >30)
• Polycystic ovary syndrome (PCOS)
• Prolonged anovulation or irregular cycles
• Tamoxifen use
• Family history of Lynch syndrome (30-60% lifetime endometrial cancer risk) 5

If Current Symptoms Exist

Any of these mandate immediate evaluation regardless of imaging:

• Abnormal uterine bleeding
• Postmenopausal bleeding
• Intermenstrual bleeding
• Persistent discharge

The Diagnostic Pathway

Optimal sequence 5:

1. Transvaginal ultrasound (first-line, measures thickness)
2. If thickened: Endometrial biopsy (Pipelle/Vabra device)
3. If biopsy negative but suspicion remains: Saline infusion sonohysterography (distinguishes focal vs. diffuse pathology)
4. If still inconclusive: Hysteroscopy with directed biopsy (gold standard, highly accurate for diagnosis)

Common Pitfalls to Avoid

• Don't wait for symptoms: 10% of endometrial cancers present without bleeding 5
• Don't accept "watchful waiting": The original finding was too abnormal
• Don't rely on ultrasound alone: It cannot distinguish benign from malignant thickening 1
• Don't accept insufficient biopsy as reassuring: Demand repeat sampling or hysteroscopy 6

Bottom Line

You are not "cooked," but you are overdue for evaluation. The 27 mm heterogeneous endometrium from two years ago was a red flag that required follow-up. Schedule repeat imaging immediately, and be prepared for endometrial sampling based on current findings. Early detection of endometrial pathology is highly treatable, but delays allow progression from benign to premalignant to malignant disease.